Great Lakes Advisors LLC Purchases 85,901 Shares of Kenvue Inc. $KVUE

Great Lakes Advisors LLC boosted its position in Kenvue Inc. (NYSE:KVUE) by 42.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 289,626 shares of the company’s stock after buying an additional 85,901 shares during the quarter. Great Lakes Advisors LLC’s holdings in Kenvue were worth $4,701,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Valeo Financial Advisors LLC lifted its position in Kenvue by 92.1% during the 3rd quarter. Valeo Financial Advisors LLC now owns 31,564 shares of the company’s stock worth $512,000 after buying an additional 15,135 shares in the last quarter. Phoenix Financial Ltd. raised its holdings in Kenvue by 43.8% during the third quarter. Phoenix Financial Ltd. now owns 14,412 shares of the company’s stock worth $234,000 after acquiring an additional 4,391 shares in the last quarter. Belpointe Asset Management LLC raised its holdings in Kenvue by 3.6% during the third quarter. Belpointe Asset Management LLC now owns 40,606 shares of the company’s stock worth $659,000 after acquiring an additional 1,404 shares in the last quarter. Chilton Capital Management LLC bought a new position in Kenvue in the third quarter valued at approximately $121,000. Finally, Callahan Advisors LLC bought a new position in Kenvue in the third quarter valued at approximately $1,307,000. Institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

KVUE has been the subject of several recent analyst reports. Johnson Rice reissued a “neutral” rating on shares of Kenvue in a report on Tuesday, October 28th. Edward Jones downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Evercore ISI set a $18.00 price objective on shares of Kenvue in a research note on Tuesday, October 28th. UBS Group cut their target price on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and thirteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $19.90.

Insider Transactions at Kenvue

In other Kenvue news, Director Jeffrey C. Smith bought 3,200,000 shares of the firm’s stock in a transaction on Friday, December 12th. The shares were purchased at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the transaction, the director directly owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.68% of the stock is owned by corporate insiders.

Kenvue Stock Up 1.2%

Kenvue stock opened at $17.41 on Friday. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17. The stock has a market cap of $33.36 billion, a P/E ratio of 23.21 and a beta of 0.60. The company’s 50-day moving average price is $17.16 and its two-hundred day moving average price is $18.04. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last announced its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The company had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. During the same quarter last year, the company earned $0.28 earnings per share. The firm’s quarterly revenue was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be paid a $0.2075 dividend. The ex-dividend date is Wednesday, February 11th. This represents a $0.83 annualized dividend and a yield of 4.8%. Kenvue’s payout ratio is 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.